Funding for this research was provided by:
Instituto de Salud Carlos III (FIS PI14/01682)
Red de investigación Cardiovascular (RD12/0042/0047)
Text and Data Mining valid from 2018-11-01
Received: 2 April 2018
Accepted: 19 October 2018
First Online: 1 November 2018
Ethics approval and consent to participate
: Written informed consent was obtained from each patient. The investigation conforms with the principles outlined in the Declaration of Helsinki. The local ethic committee from the Hospital Universitari de Bellvitge approved the study, ref.: PR088/16.
: Not applicable.
: JCC has received speaking fees from Vifor Pharma and was a member of the steering committee of the FAIR-HF and CONFIRM-HF studies. None of the other authors have any conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.